BIOMAT Database Logo BIOMAT Database Logo

Editorial: Autoantibodies in Kidney Diseases. 2020

Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities
D019468 Disease Management A broad approach to appropriate coordination of the entire disease treatment process that often involves shifting away from more expensive inpatient and acute care to areas such as preventive medicine, patient counseling and education, and outpatient care. This concept includes implications of appropriate versus inappropriate therapy on the overall cost and clinical outcome of a particular disease. (From Hosp Pharm 1995 Jul;30(7):596) Disease Managements,Management, Disease,Managements, Disease

Related Publications

Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
[Autoantibodies in kidney diseases].
August 1994, Zeitschrift fur arztliche Fortbildung,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
[The complement titer and kidney autoantibodies in diffuse kidney diseases].
December 1966, Terapevticheskii arkhiv,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Editorial: Genetics of Kidney Diseases.
January 2020, Frontiers in genetics,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Editorial: Autoantibodies.
January 2019, Frontiers in immunology,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Editorial: Nutrition and metabolism in kidney diseases.
January 2023, Frontiers in nutrition,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Editorial: Genetic Kidney Diseases of Childhood.
January 2018, Frontiers in pediatrics,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
[The complement titer and renal autoantibodies in diffuse kidney diseases].
December 1966, Terapevticheskii arkhiv,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
[Do kidney-specific autoantibodies have a future in the diagnosis of kidney diseases?].
May 1974, Die Medizinische Welt,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Editorial: Role of complement activation in kidney diseases.
January 2023, Frontiers in medicine,
Kevin J Marchbank, and Ashley Frazer-Abel, and Marie-Agnes Dragon-Durey, and Bradley P Dixon
Editorial: Clinical application of proteomics in kidney diseases.
January 2022, Frontiers in medicine,
Copied contents to your clipboard!